The FLT3 internal tandem duplication mutation at disease diagnosis is a negative prognostic factor in myelodysplastic syndrome patients

2022 ◽  
pp. 106790
Author(s):  
Ritsu Sumiyoshi ◽  
Haruko Tashiro ◽  
Ryosuke Shirasaki ◽  
Takuji Matsuo ◽  
Tadashi Yamamoto ◽  
...  
2008 ◽  
Vol 183 (2) ◽  
pp. 89-93 ◽  
Author(s):  
Ronald Feitosa Pinheiro ◽  
Eloisa de Sá Moreira ◽  
Maria Regina Régis Silva ◽  
Fernando Lopes Alberto ◽  
Maria de Lourdes L.F. Chauffaille

2007 ◽  
Vol 29 (9) ◽  
pp. 666-667 ◽  
Author(s):  
Akira Shimada ◽  
Takeshi Taketani ◽  
Akira Kikuchi ◽  
Ryoji Hanada ◽  
Hiroshi Arakawa ◽  
...  

Blood ◽  
2014 ◽  
Vol 123 (6) ◽  
pp. 905-913 ◽  
Author(s):  
Erika K. Keeton ◽  
Kristen McEachern ◽  
Keith S. Dillman ◽  
Sangeetha Palakurthi ◽  
Yichen Cao ◽  
...  

Key Points AZD1208 is a selective pan-Pim kinase inhibitor with efficacy in AML cells, xenografts, and Flt3-internal tandem duplication or Flt3 wild-type patient samples. AML cell growth inhibition is associated with suppression of p70S6K, 4EBP1 phosphorylation, and messenger RNA translation.


2007 ◽  
Vol 42 (3) ◽  
pp. 250 ◽  
Author(s):  
Sang-Ho Kim ◽  
Yeo-Kyeoung Kim ◽  
Il-Kwon Lee ◽  
Deog-Yeon Jo ◽  
Jong-Ho Won ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document